Interlocked silk sericin hollow particle aggregates with enhanced adaptability and progressive solubility for sustained drug release.

Authors

Weitao Zhou, Tiantian Zha, Zeng Qu, Ning Li, Jikai Chen, Yaru Li, Yifan Liu, YuHan Song, Yiwen Feng, Xiaoyan Sun, Jingliang Li, Qi Han, Shan Du

Published in

International journal of biological macromolecules. Pages 155036. Oct 25, 2026. Epub Oct 25, 2026.

Abstract

The ever-increasing demand for multifunctional delivery carriers has considerably stimulated the need for durable, safe, and superior delivery materials. However, the straightforward and scalable fabrication of adaptable particle aggregates that exhibit biocompatibility, desirable textural characteristics, and high performance remains a big challenge. Herein, we present the creation of bulk silk sericin aggregates (SSAs) via a process involving spray drying followed by vacuum-assisted UV irradiation. These aggregates comprise interlocked hollow particles with an average diameter of 4.94 ± 0.23 μm, reminiscent of pomegranate seeds, which confer enhanced storability. Importantly, these bulk SSAs exhibit enhanced formability and water tolerance, with progressive dissolution due to the transformation of β-sheets (39.72%) from random coils induced by chemical crosslinking and compression. Simultaneously, the SSAs demonstrate favorable vascular compatibility, as evidenced by a hemolysis ratio of only 0.89% and an endpoint scoring value of 0.30. These distinctive characteristics enhance the adaptability of the SSAs for practical applications across various environments. The loaded SSAs exhibit markedly different release profiles for 5-fluorouracil, with a cumulative release of 73.21% at pH 7.4 compared to just 0.25% at pH 4.0 over 180 h. This work offers a sustainable fabrication strategy for the development of bulk drug delivery materials, underscoring their considerable potential for advanced drug delivery and therapeutic applications.

PMID:
42927817
Bibliographic data and abstract were imported from PubMed on 26 Oct 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.